Revolution Medicines, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-67.7M | — |
| FY2018 | — | $-108.4M | $69.6M |
| FY2019 | — | $-152.6M | $16.7M |
| FY2020 | — | $474.7M | $104.3M |
| FY2021 | — | $602.6M | $108.5M |
| FY2022 | — | $685.2M | $161.4M |
| FY2023 | — | $1.83B | $696.1M |
| FY2024 | — | $2.27B | $543.1M |
| FY2025 | — | $1.63B | $383.7M |